Perspectives: Direct and specific inhibition of factor Xa: an emerging therapeutic strategy for atherothrombotic disease
- 1 January 2014
- journal article
- Published by Oxford University Press (OUP) in European Heart Journal Supplements
- Vol. 16 (suppl A), A56-A60
- https://doi.org/10.1093/eurheartj/sut013
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2012 UpdateCirculation, 2012
- Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome?Thrombosis Research, 2011
- The Year in Non–ST-Segment Elevation Acute Coronary SyndromeJournal of the American College of Cardiology, 2011
- Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registryNature Clinical Practice Cardiovascular Medicine, 2008
- Comparison of Fondaparinux and Enoxaparin in Acute Coronary SyndromesNew England Journal of Medicine, 2006
- Effects of Fondaparinux on Mortality and Reinfarction in Patients With Acute ST-Segment Elevation Myocardial Infarction: The OASIS-6 Randomized TrialJAMA, 2006
- Warfarin plus Aspirin after Myocardial Infarction or the Acute Coronary Syndrome: Meta-Analysis with Estimates of Risk and BenefitAnnals of Internal Medicine, 2005
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Thrombin signalling and protease-activated receptorsNature, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999